Nachman Eckstein

423 total citations
29 papers, 348 citations indexed

About

Nachman Eckstein is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Genetics. According to data from OpenAlex, Nachman Eckstein has authored 29 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Reproductive Medicine and 7 papers in Genetics. Recurrent topics in Nachman Eckstein's work include Menopause: Health Impacts and Treatments (7 papers), Ovarian function and disorders (6 papers) and Estrogen and related hormone effects (6 papers). Nachman Eckstein is often cited by papers focused on Menopause: Health Impacts and Treatments (7 papers), Ovarian function and disorders (6 papers) and Estrogen and related hormone effects (6 papers). Nachman Eckstein collaborates with scholars based in Israel, United States and Belgium. Nachman Eckstein's co-authors include Daniel Ayalon, Rona Limor, Enrique Z. Fisman, Amos Pines, Ofer Barnea, M. Ferin, Yaacov Drory, Michael Motro, Itzhak Shapira and P. W. Carmel and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

Nachman Eckstein

29 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nachman Eckstein Israel 10 149 104 83 68 62 29 348
E.N. Cole United Kingdom 12 183 1.2× 103 1.0× 53 0.6× 77 1.1× 26 0.4× 19 452
G.F. Argenio Italy 11 307 2.1× 53 0.5× 77 0.9× 49 0.7× 28 0.5× 19 442
E. Koh Japan 12 76 0.5× 75 0.7× 112 1.3× 109 1.6× 48 0.8× 37 410
J.B. Fishback United States 8 172 1.2× 36 0.3× 49 0.6× 45 0.7× 10 0.2× 11 355
D. Lanzetta Italy 12 189 1.3× 86 0.8× 218 2.6× 61 0.9× 168 2.7× 22 499
Jackie Barley United Kingdom 7 136 0.9× 92 0.9× 59 0.7× 42 0.6× 6 0.1× 8 385
Juana Sellés Argentina 13 121 0.8× 115 1.1× 17 0.2× 108 1.6× 27 0.4× 20 372
M T Pham-Huu-Trung France 13 305 2.0× 49 0.5× 40 0.5× 182 2.7× 11 0.2× 18 448
MarkéŽta Vaňkov‡á Czechia 15 157 1.1× 111 1.1× 211 2.5× 125 1.8× 157 2.5× 48 642
A. Faedda Italy 10 322 2.2× 79 0.8× 48 0.6× 121 1.8× 14 0.2× 22 446

Countries citing papers authored by Nachman Eckstein

Since Specialization
Citations

This map shows the geographic impact of Nachman Eckstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nachman Eckstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nachman Eckstein more than expected).

Fields of papers citing papers by Nachman Eckstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nachman Eckstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nachman Eckstein. The network helps show where Nachman Eckstein may publish in the future.

Co-authorship network of co-authors of Nachman Eckstein

This figure shows the co-authorship network connecting the top 25 collaborators of Nachman Eckstein. A scholar is included among the top collaborators of Nachman Eckstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nachman Eckstein. Nachman Eckstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weintraub, Moshe, Itamar Grosskopf, Gideon Charach, Nachman Eckstein, & Ardon Rubinstein. (1999). Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women. Metabolism. 48(9). 1193–1196. 21 indexed citations
3.
Weintraub, Moshe, Itamar Grosskopf, Gideon Charach, et al.. (1998). Fluctuations of Lipid and Lipoprotein Levels in Hyperlipidemic Postmenopausal Women Receiving Hormone Replacement Therapy. Archives of Internal Medicine. 158(16). 1803–1803. 9 indexed citations
4.
Pines, Amos, Nachman Eckstein, Iris Dotan, et al.. (1998). Effect of Estradiol on Rat Ileum. General Pharmacology The Vascular System. 31(5). 735–736. 6 indexed citations
5.
Pines, Amos, Enrique Z. Fisman, Yaacov Drory, et al.. (1998). The Effects of Sublingual Estradiol on Left Ventricular Function at Rest and Exercise in Postmenopausal Women. Menopause The Journal of The North American Menopause Society. 5(2). 79???85–79???85. 26 indexed citations
6.
Averbuch, Mordechai, Daniel Ayalon, Nachman Eckstein, et al.. (1998). Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.. PubMed. 29(5-6). 343–50. 4 indexed citations
7.
Pines, Amos, Enrique Z. Fisman, Itzhak Shapira, et al.. (1996). Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension. The American Journal of Cardiology. 78(12). 1385–1389. 40 indexed citations
8.
Eckstein, Nachman, et al.. (1994). Acute effects of 17β-estradiol on the rat heart. American Journal of Obstetrics and Gynecology. 171(3). 844–848. 34 indexed citations
9.
Eckstein, Nachman, Amos Pines, Enrique Z. Fisman, et al.. (1994). The Effect of the Hypoestrogenic State, Induced by Gonadotropin-Releasing Hormone Agonist, on Doppler-Derived Parameters of Aortic Flow. Obstetrical & Gynecological Survey. 49(3). 204–205. 2 indexed citations
10.
Schally, Andrew V., et al.. (1993). Inhibitory Effect of a Highly Potent Antagonist of LH Releasing Hormone (SB-75) on the Pituitary Gonadal Axis in the Intact and Castrated Rat. Neuroendocrinology. 58(2). 153–159. 4 indexed citations
11.
Levy, Tally, et al.. (1993). Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders. Human Reproduction. 8(6). 834–839. 22 indexed citations
12.
Eckstein, Nachman. (1993). The effect of the hypoestrogenic state, induced by gonadotropin- releasing hormone agonist, on Doppler-derived parameters of aortic flow. The Journal of Clinical Endocrinology & Metabolism. 77(4). 910–912. 4 indexed citations
13.
14.
Eckstein, Nachman, J. Földes, R. Steinberg, et al.. (1992). Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist. Maturitas. 15(1). 25–32. 6 indexed citations
15.
Dicker, Dov, et al.. (1989). Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist(buserelin). Human Reproduction. 4(3). 250–251. 10 indexed citations
16.
Ayalon, Daniel, et al.. (1988). Diagnosis of a small ovarian tumor (androgen secreting) by magnetic resonance: A new noninvasive procedure. American Journal of Obstetrics and Gynecology. 159(4). 903–905. 6 indexed citations
17.
Ayalon, Daniel, M. Ben-David, Robert C. Wohl, et al.. (1988). Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease. Gynecological Endocrinology. 2(4). 319–330. 3 indexed citations
18.
Eckstein, Nachman, et al.. (1985). Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin. Fertility and Sterility. 44(6). 744–750. 5 indexed citations
19.
Bergman, Arieh, et al.. (1982). Fetal Distress Due to Intravenous Administration of Pethidine (Meperidine) with Promethazine During Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology. 22(4). 215–217. 3 indexed citations
20.
Ayalon, Daniel, et al.. (1982). Effects of long‐term treatment with bromocriptine on pituitary prolactinoma in a male. International Journal of Gynecology & Obstetrics. 20(6). 481–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.N. Cole Breakdown of academic impact, for papers by G.F. Argenio Breakdown of academic impact, for papers by E. Koh Breakdown of academic impact, for papers by J.B. Fishback Breakdown of academic impact, for papers by D. Lanzetta Breakdown of academic impact, for papers by Jackie Barley Breakdown of academic impact, for papers by Juana Sellés Breakdown of academic impact, for papers by M T Pham-Huu-Trung Breakdown of academic impact, for papers by MarkéŽta Vaňkov‡á Breakdown of academic impact, for papers by A. Faedda
Rankless by CCL
2026